Novo Nordisk's pricing strategies inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price tag gouging, mentioning the stark distinction amongst U.S. price ranges and those in Europe and copyright. The company suggests that prope